FDA
-
-
-
-
-
-
-
Virios Therapeutics Announces Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID
-
-
-
-
-
-
-
Virios Therapeutics Announces Termination of At-The-Market Sales Agreement
-
-
-
-
-
-
-
Virios Therapeutics to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
-
-
-
-
-
-
-
Virios Therapeutics Announces Initial FDA Feedback on Proposed IMC-1 Phase 3 Program for Treatment of Fibromyalgia
-
-
-
-
-
-
-
Virios Therapeutics, Inc. to Present at the Virtual Planet MicroCap Showcase
-
322,899 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

